Retraction to: Down-regulation of uPA and uPAR by 3, 3′-diindolylmethane contributes to the inhibition of cell growth and migration of breast cancer cells (J Cell Biochem, 2009, 108, (916-925), 10.1002/jcb.22323);Down-regulation of uPA and uPAR by 3,3′-diindolylmethane contributes to the inhibition of cell growth and migration of breast cancer cells

Journal of Cellular Biochemistry

Volumn 108, Issue 4, 2009, Pages 916-925

  Ahmad, Aamir ^a   Kong, Dejuan ^a   Wang, Zhiwei ^a   Sarkar, Sanila H ^a   Banerjee, Sanjeev ^a   Sarkar, Fazlul H ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

3; 3 diindolylmethane; Breast cancer; MCF 7; MDA MB 231; Migration; MMP 9; uPA; uPAR; VEGF

Indexed keywords

3,3' DIINDOLYLMETHANE; GELATINASE B; UROKINASE; UROKINASE RECEPTOR; VASCULOTROPIN;

ARTICLE; BIOLOGICAL ACTIVITY; BREAST CANCER; CANCER CELL CULTURE; CANCER INHIBITION; CANCER INVASION; CONTROLLED STUDY; DOWN REGULATION; GENE SILENCING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 70350500114     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.25583     Document Type: Erratum

References (42)

1. Ahmad A, Banerjee S, Wang Z, Kong D, Sarkar FH. 2008. Plumbagin-induced apoptosis of human breast cancer cells is mediated by inactivation of NF-kappaB and Bcl-2. J Cell Biochem 105:1461-1471.
2. Ahmad A, Kong D, Sarkar SH, Wang Z, Banerjee S, Sarkar FH. 2009. Inactivation of uPA and its receptor uPAR by 3,3′-diindolylmethane (DIM) leads to the inhibition of prostate cancer cell growth and migration. J Cell Biochem 107:516-527.
3. Ali S, Banerjee S, Ahmad A, El-Rayes BF, Philip PA, Sarkar FH. 2008. Apoptosis-inducing effect of erlotinib is potentiated by 3,3′- diindolylmethane in vitro and in vivo using an orthotopic model of pancreatic cancer. Mol Cancer Ther 7:1708-1719.
4. Anderton MJ, Manson MM, Verschoyle R, Gescher A, Steward WP, Williams ML, Mager DE. 2004. Physiological modeling of formulated and crystalline 3,3′-diindolylmethane pharmacokinetics following oral administration in mice. Drug Metab Dispos 32:632-638. (Pubitemid 38668156)
5. Bhuiyan MM, Li Y, Banerjee S, Ahmed F, Wang Z, Ali S, Sarkar FH. 2006. Down-regulation of androgen receptor by 3,3′-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in both hormone-sensitive LNCaP and insensitive C4-2B prostate cancer cells. Cancer Res 66:10064-10072. (Pubitemid 44672060)
6. Bradlow HL. 2008. Review. Indole-3-carbinol as a chemoprotective agent in breast and prostate cancer. In Vivo 22:441-445.
7. Carmeliet P, Moons L, Dewerchin M, Rosenberg S, Herbert JM, Lupu F, Collen D. 1998. Receptor-independent role of urokinase-type plasminogen activator in pericellular plasmin and matrix metalloproteinase proteolysis during vascular wound healing in mice. J Cell Biol 140:233-245. (Pubitemid 28070910)
8. Chang X, Tou JC, Hong C, Kim HA, Riby JE, Firestone GL, Bjeldanes LF. 2005. 3,3′-Diindolylmethane inhibits angiogenesis and the growth of transplantable human breast carcinoma in athymic mice. Carcinogenesis 26:771-778. (Pubitemid 41214339)
9. Dass K, Ahmad A, Azmi AS, Sarkar SH, Sarkar FH. 2008. Evolving role of uPA/uPAR system in human cancers. Cancer Treat Rev 34:122-136.
10. Degner SC, Papoutsis AJ, Selmin O, Romagnolo DF. 2009. Targeting of aryl hydrocarbon receptor-mediated activation of cyclooxygenase-2 expression by the indole-3-carbinol metabolite 3,3′-diindolylmethane in breast cancer cells. J Nutr 139:26-32.
11. Giannopoulou I, Mylona E, Kapranou A, Mavrommatis J, Markaki S, Zoumbouli C, Keramopoulos A, Nakopoulou L. 2007. The prognostic value of the topographic distribution of uPAR expression in invasive breast carcinomas. Cancer Lett 246:262-267. (Pubitemid 44959396)
12. Gong Y, Sohn H, Xue L, Firestone GL, Bjeldanes LF. 2006. 3,3′-Diindolylmethane is a novel mitochondrial H(+)-ATP synthase inhibitor that can induce p21(Cip1/Waf1) expression by induction of oxidative stress in human breast cancer cells. Cancer Res 66:4880-4887.
13. Gutova M, Najbauer J, Frank RT, Kendall SE, Gevorgyan A, Metz MZ, Guevorkian M, Edmiston M, Zhao D, Glackin CA, Kim SU, Aboody KS. 2008. Urokinase plasminogen activator and urokinase plasminogen activator receptor mediate human stem cell tropism to malignant solid tumors. Stem Cells 26:1406-1413.
14. Heber D, Bowerman S. 2001. Applying science to changing dietary patterns. J Nutr 131:3078S-3081S. (Pubitemid 33070783)
15. Higdon JV, Delage B, Williams DE, Dashwood RH. 2007. Cruciferous vegetables and human cancer risk: Epidemiologic evidence and mechanistic basis. Pharmacol Res 55:224-236. (Pubitemid 46518152)
16. Hildenbrand R, Schaaf A, Dorn-Beineke A, Allgayer H, Sutterlin M, Marx A, Stroebel P. 2009. Tumor stroma is the predominant uPA-, uPAR-, PAI-1-expressing tissue in human breast cancer: Prognostic impact. Histol Histopathol 24:869-877.
17. Hong C, Firestone GL, Bjeldanes LF. 2002a. Bcl-2 family-mediated apoptotic effects of 3,3′-diindolylmethane (DIM) in human breast cancer cells. Biochem Pharmacol 63:1085-1097. (Pubitemid 34267024)
18. Hong C, Kim HA, Firestone GL, Bjeldanes LF. 2002b. 3,3′- Diindolylmethane (DIM) induces a G(1) cell cycle arrest in human breast cancer cells that is accompanied by Sp1-mediated activation of p21(WAF1/CIP1) expression. Carcinogenesis 23:1297-1305.
19. Hsu EL, Chen N, Westbrook A, Wang F, Zhang R, Taylor RT, Hankinson O. 2008. CXCR4 and CXCL12 down-regulation: A novel mechanism for the chemoprotection of 3,3′-diindolylmethane for breast and ovarian cancers. Cancer Lett 265:113-123.
20. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. 2009. Cancer statistics. CA Cancer J Clin 59:225-249.
21. Kim EJ, Park SY, Shin HK, Kwon DY, Surh YJ, Park JH. 2007. Activation of caspase-8 contributes to 3,3′-Diindolylmethane-induced apoptosis in colon cancer cells. J Nutr 137:31-36. (Pubitemid 46052855)
22. Kong D, Li Y, Wang Z, Banerjee S, Sarkar FH. 2007. Inhibition of angiogenesis and invasion by 3,3′-diindolylmethane is mediated by the nuclear factor-kappaB downstream target genes MMP-9 and uPA that regulated bioavailability of vascular endothelial growth factor in prostate cancer. Cancer Res 67:3310-3319. (Pubitemid 46724870)
23. Koopman JL, Slomp J, de Bart AC, Quax PH, Verheijen JH. 1998. Mitogenic effects of urokinase on melanoma cells are independent of high affinity binding to the urokinase receptor. J Biol Chem 273:33267-33272. (Pubitemid 29005701)
24. Kunigal S, Lakka SS, Gondi CS, Estes N, Rao JS. 2007. RNAi-mediated downregulation of urokinase plasminogen activator receptor and matrix metalloprotease-9 in human breast cancer cells results in decreased tumor invasion, angiogenesis and growth. Int J Cancer 121:2307-2316. (Pubitemid 47585614)
25. Li Y, Wang Z, Kong D, Murthy S, Dou QP, Sheng S, Reddy GP, Sarkar FH. 2007. Regulation of FOXO3a/beta-catenin/GSK-3beta signaling by 3,3′-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in prostate cancer cells. J Biol Chem 282:21542-21550. (Pubitemid 47099972)
26. Nachshon-Kedmi M, Fares FA, Yannai S. 2004a. Therapeutic activity of 3,3′0-diindolylmethane on prostate cancer in an in vivo model. Prostate 61:153-160. (Pubitemid 39244702)
27. Nachshon-Kedmi M, Yannai S, Fares FA. 2004b. Induction of apoptosis in human prostate cancer cell line, PC3, by 3,3′-diindolylmethane through the mitochondrial pathway. Br J Cancer 91:1358-1363. (Pubitemid 39424798)
28. Nam RK, Fleshner N, Rakovitch E, Klotz L, Trachtenberg J, Choo R, Morton G, Danjoux C. 1999. Prevalence and patterns of the use of complementary therapies among prostate cancer patients: An epidemiological analysis. J Urol 161:1521-1524. (Pubitemid 29420810)
29. Okino ST, Pookot D, Basak S, Dahiya R. 2009. Toxic and chemopreventive ligands preferentially activate distinct aryl hydrocarbon receptor pathways: Implications for cancer prevention. Cancer Prev Res (Phila, PA) 2:251-256.
30. Pacheco MM, Nishimoto IN, Mourao NM, Mantovani EB, Brentani MM. 2001. Prognostic significance of the combined expression of matrix metalloproteinase-9, urokinase type plasminogen activator and its receptor in breast cancer as measured by Northern blot analysis. Int J Biol Markers 16:62-68.
31. Pillay V, Dass CR, Choong PF. 2007. The urokinase plasminogen activator receptor as a gene therapy target for cancer. Trends Biotechnol 25:33-39. (Pubitemid 46001467)
32. Rahman KW, Sarkar FH. 2005. Inhibition of nuclear translocation of nuclear factor-{kappa}B contributes to 3,3′-diindolylmethane-induced apoptosis in breast cancer cells. Cancer Res 65:364-371.
33. Rahman KM, Sarkar FH, Banerjee S, Wang Z, Liao DJ, Hong X, Sarkar NH. 2006a. Therapeutic intervention of experimental breast cancer bone metastasis by indole-3-carbinol in SCID-human mouse model. Mol Cancer Ther 5:2747-2756. (Pubitemid 44849001)
34. Rahman KW, Li Y, Wang Z, Sarkar SH, Sarkar FH. 2006b. Gene expression profiling revealed survivin as a target of 3,3′-diindolylmethane-induced cell growth inhibition and apoptosis in breast cancer cells. Cancer Res 66:4952-4960.
35. Rao JS. 2003. Molecular mechanisms of glioma invasiveness: The role of proteases. Nat Rev Cancer 3:489-501.
36. Richardson MA, Sanders T, Palmer JL, Greisinger A, Singletary SE. 2000. Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol 18:2505-2514. (Pubitemid 30432515)
37. Sheng S. 2001. The urokinase-type plasminogen activator system in prostate cancer metastasis. Cancer Metastasis Rev 20:287-296. (Pubitemid 34595272)
38. Steinmetz KA, Potter JD. 1991. Vegetables, fruit, and cancer. I. Epidemiology. Cancer Causes Control 2:325-357.
39. Subramanian R, Gondi CS, Lakka SS, Jutla A, Rao JS. 2006. siRNA-mediated simultaneous downregulation of uPA and its receptor inhibits angiogenesis and invasiveness triggering apoptosis in breast cancer cells. Int J Oncol 28:831-839.
40. Wang Y. 2001. The role and regulation of urokinase-type plasminogen activator receptor gene expression in cancer invasion and metastasis. Med Res Rev 21:146-170. (Pubitemid 32185245)
41. Wang Z, Yu BW, Rahman KM, Ahmad F, Sarkar FH. 2008. Induction of growth arrest and apoptosis in human breast cancer cells by 3,3-diindolylmethane is associated with induction and nuclear localization of p27kip. Mol Cancer Ther 7:341-349. (Pubitemid 351302527)
42. Xue L, Firestone GL, Bjeldanes LF. 2005. DIM stimulates IFNgamma gene expression in human breast cancer cells via the specific activation of JNK and p38 pathways. Oncogene 24:2343-2353. (Pubitemid 40546693)